Clene Inc. (CLNN) vs Tenax Therapeutics, Inc. (TENX)

A side-by-side comparison of Clene Inc. and Tenax Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLNN vs TENX

growth of $100 · dividends reinvested · last 8y
CLNN -98.0% (-38.7%/yr)TENX -100.0% (-64.6%/yr)CLNN compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$2$0
CLNN TENX

CLNN vs TENX: by the numbers

  • •TENX is the larger company ($51M vs $49M market cap).
  • •Both run net losses; TENX's is the smaller (0.00% vs -20059.90% net margin).

Metrics side by side

Valuation

MetricCLNNTENX
P/S ratio251.03N/A
P/B ratioN/A0.45

Profitability

MetricCLNNTENX
Gross margin78.50%0.00%
Operating margin-11541.50%0.00%
Net margin-20059.90%0.00%
ROEN/A-57.10%
ROIC-109.13%-60.40%

Growth (annualized)

MetricCLNNTENX
Revenue CAGR (5Y)-18.30%N/A
Total return CAGR (5Y)-51.16%-76.80%

Frequently asked

How have CLNN and TENX total returns compared?
Over the past 5 years, CLNN delivered -51.16% and TENX delivered -76.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.